TEST:

ExoDx™ Prostate (IntelliScore) Test

Next Monday-14 Nov 2022 at Noon. Delighted to be presenting -Medscape CME program on Prostate Cancer Screening and Secondary testing including Exo Dx and PHI. Free registration https://t.co/Ifp6fiVXji ()

Biomarkers Accurately Inform Treatment Decisions in Localized Prostate Cancer https://t.co/pn6QBv0NhP Here is recent brief review of prostate biomarkers including PHI, EXO Dx, Decipher, Oncotype. (@JuddMoul)

Thanks for the Shout Out. This was looking at how we use Exo Dx urine assay as a secondary screening test for prostate cancer in our program @DukeGUCancer @DukeUrology Our goal is to improve care for high risk and underserved men @Duke_FamMed ()

"How about comparison on the utility of advanced Prostate cancer screening tests such as SelectMDx, ExoDx, PHI and 4K score? Any objective guidance?" (@shaker_leonard)